-
公开(公告)号:US20240254161A1
公开(公告)日:2024-08-01
申请号:US18583364
申请日:2024-02-21
Applicant: Janssen Biotech, Inc.
Inventor: Vipul Bhargava , Vinod Krishna , David J. Pocalyko , Pegah Safabakhsh , Manuel Alejandro Sepulveda
CPC classification number: C07K2/00 , A61K45/06 , C07K1/107 , C12N15/86 , A61K38/00 , C12N2710/10041 , C12N2710/24041
Abstract: The disclosure relates to ovarian cancer neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the ovarian cancer neoantigens, and methods of making and using them.
-
公开(公告)号:US11945881B2
公开(公告)日:2024-04-02
申请号:US17174505
申请日:2021-02-12
Applicant: Janssen Biotech, Inc.
Inventor: Vipul Bhargava , Vinod Krishna , David J. Pocalyko , Pegah Safabakhsh , Manuel Alejandro Sepulveda
CPC classification number: C07K2/00 , A61K45/06 , C07K1/107 , C12N15/86 , A61K38/00 , C12N2710/10041 , C12N2710/24041
Abstract: The disclosure relates to ovarian cancer neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the ovarian cancer neoantigens, and methods of making and using them.
-
公开(公告)号:US20210261636A1
公开(公告)日:2021-08-26
申请号:US17174590
申请日:2021-02-12
Applicant: Janssen Biotech, Inc.
Inventor: Vipul BHARGAVA , Vinod Krishna , Jaymala Patel , David J. Pocalyko , Yashoda Rani Rajpurohit , Pegah Safabakhsh , Manuel Alejandro Sepulveda
Abstract: The disclosure relates to multiple myeloma neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the multiple myeloma neoantigens, and methods of making and using them.
-
公开(公告)号:US20210261609A1
公开(公告)日:2021-08-26
申请号:US17174505
申请日:2021-02-12
Applicant: Janssen Biotech, Inc.
Inventor: Vipul BHARGAVA , Vinod Krishna , David J. Pocalyko , Pegah Safabakhsh , Manuel Alejandro Sepulveda
Abstract: The disclosure relates to ovarian cancer neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the ovarian cancer neoantigens, and methods of making and using them.
-
-
-